Trial NCT00384865

View at ClinicalTrials.gov 
Org. Study IDs: 458
Secondary IDs: R01HL082895-01

Last trial update was posted on 2017-07-21

MeSH Interventions

Aspirin Simvastatin

MeSH Conditions

Hypertension Hypertension, Pulmonary Pulmonary Arterial Hypertension

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

The primary end point that should be used in early-stage clinical trials in PAH is uncertain. We did not include invasive hemodynamic end points. Early termination led to missing data for those active subjects in the trial at termination (n16).

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID